SCHEMBL5178523

SCHEMBL5178523

NC(=O)Oc1ccc2[nH]c(-c3ccc(C(F)(F)c4ccc5c(c4)OCO5)cc3)nc2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK2 O96017 12/20 0.52
▸ CYP3A4 P08684 3/20 0.44
▸ CYP2D6 P10635 3/20 0.44
▸ MAPT P10636 3/20 0.44
▸ CYP2C19 P33261 3/20 0.44
▸ KDM4E B2RXH2 2/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PARP1 P09874 1/20 0.43
▸ SIRT2 Q8IXJ6 1/20 0.42
▸ SIRT1 Q96EB6 1/20 0.42
▸ SIRT3 Q9NTG7 1/20 0.42
▸ CYP1A2 P05177 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ ALDH1A1 P00352 2/20 0.38
▸ HPGD P15428 2/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3575508 0.86 CHEK2 (0.62) CHEK2CYP3A4CYP2D6MAPTCYP2C19
SCHEMBL5253625 0.85 CHEK2 (0.69) CHEK2CYP3A4CYP2D6MAPTCYP2C19
SCHEMBL5178035 0.84 CHEK2 (0.67) CHEK2CYP3A4CYP2D6MAPTCYP2C19
SCHEMBL5177618 0.83 CHEK2 (0.51) CHEK2MEN1KMT2A
SCHEMBL5177920 0.82 CHEK2 (0.66) CHEK2CYP3A4CYP2D6MAPTCYP2C19
SCHEMBL1382147 0.80 CHEK2 (0.73) CHEK2SIRT2SIRT1SIRT3
SCHEMBL5254723 0.79 CHEK2 (0.67) CHEK2MEN1KMT2APARP1
SCHEMBL5178851 0.78 CHEK2 (0.67) CHEK2CYP3A4CYP2D6MAPTCYP2C19
SCHEMBL5176577 0.77 CHEK2 (0.66) CHEK2MAPTKDM4EMEN1KMT2A
SCHEMBL5178365 0.77 CHEK2 (0.67) CHEK2CYP3A4CYP2D6MAPTCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613313-B1 2-PHENYL-BENZIMIDAZOL AND 2-PHENYL-IMIDAZO-4,5]-PYRIDINE DERIVATIVES AS CHECKPOINT KINASE CDS1 (CHK2) INHIBITORS FOR THE TREATMENT OF CANCER JANSSEN PHARMACEUTICA NV (BE) 2007-06-06 — — EP claimed
Send feedback